Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 03, 2025 07:00 ET | Source: Rome Therapeutics, Inc.

ROME Therapeutics Announces Publication in Nature Communications of First Large-Scale, Pan-Cancer Analysis of LINE-1 Expression Levels and Retrotransposon Activity

Data revealed high correlation between LINE-1 expression and retrotransposon (RT) burden, with variability across tumor types and genomic loci, demonstrating the potential for precision LINE-1...
November 21, 2024 07:00 ET | Source: Rome Therapeutics, Inc.

ROME Therapeutics Debuts First Preclinical Data of its LINE-1 Reverse Transcriptase (RT) Inhibitors in Neurodegenerative Diseases at 3rd Annual Dark Genome Symposium

ROME Therapeutics debuts first preclinical data of its LINE-1 RT inhibitors in neurodegenerative diseases at 3rd Annual Dark Genome Symposium in NYC.
November 07, 2024 08:00 ET | Source: Rome Therapeutics, Inc.

ROME Therapeutics to Present Data Supporting LINE-1 Reverse Transcriptase Inhibitors as a Novel Treatment for Autoimmune Diseases at ACR Convergence 2024

BOSTON, Nov. 07, 2024 (GLOBE NEWSWIRE) -- ROME Therapeutics, a biotechnology company illuminating the intersection of the dark genome and innate immunity to develop breakthrough medicines for...
October 08, 2024 05:00 ET | Source: Rome Therapeutics, Inc.

ROME Therapeutics, Enara Bio, Nucleome Therapeutics and NYU Langone Health to Host 3rd Annual Dark Genome Symposium

ROME Therapeutics, Enara Bio, Nucleome Therapeutics and NYU Langone Health will host the 3rd Annual Dark Genome Symposium on Nov. 21 - 22 in New York, NY.
September 11, 2024 07:00 ET | Source: Rome Therapeutics, Inc.

ROME Therapeutics to Participate in 2024 Cantor Global Healthcare Conference

BOSTON, Sept. 11, 2024 (GLOBE NEWSWIRE) -- ROME Therapeutics, a biotechnology company harnessing the power of the dark genome to develop breakthrough medicines for serious diseases, today announced...
August 12, 2024 07:00 ET | Source: Rome Therapeutics, Inc.

ROME Therapeutics to Participate in 2024 Wedbush PacGrow Healthcare Conference

ROME Therapeutics' President, CEO and Co-Founder, Rosana Kapeller, M.D., Ph.D., will participate in the 2024 Wedbush PacGrow Healthcare Conference.